Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction (Q32034638)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Group II metabotropic glutamate receptor activation protects striatal dopaminergic nerve terminals against MPP+-induced neurotoxicity along with brain-derived neurotrophic factor induction (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

toxic encephalopathy

1 reference

based on heuristic

inferred from title

author name string

Matarredona ER

1

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Santiago M

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Venero JL

3

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Cano J

4

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Machado A

5

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

language of work or name

0 references

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Journal of Neurochemistry

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

76

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

351-360

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

Selective activation of group-II metabotropic glutamate receptors is protective against excitotoxic neuronal death.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Neuroprotective effects of a systemically active group II metabotropic glutamate receptor agonist LY354740 in a gerbil model of global ischaemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Group I mGlu receptor modulation of dopamine release in the rat striatum in vivo

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

The non-competitive NMDA-receptor antagonist MK-801 prevents the massive release of glutamate and aspartate from rat striatum induced by 1-methyl-4-phenylpyridinium (MPP+).

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Identification of potential compounds promoting BDNF production in nigral dopaminergic neurons: clinical implication in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Pharmacology and functions of metabotropic glutamate receptors

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Molecular profile of reactive astrocytes--implications for their role in neurologic disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from 1-methyl-4-phenylpyridinium toxicity in vitro

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Functional recovery in parkinsonian monkeys treated with GDNF

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Brain-derived and glial cell line-derived neurotrophic factors protect a catecholaminergic cell line from dopamine-induced cell death

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Microglia: a sensor for pathological events in the CNS

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Do NMDA receptor antagonists protect against MPTP-toxicity? Biochemical and immunocytochemical analyses in black mice

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Lack of involvement of glutamate-induced excitotoxicity in MPP+ toxicity in striatal dopaminergic terminals: possible involvement of ascorbate

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Anticonvulsive and neuroprotective actions of a potent agonist (DCG-IV) for group II metabotropic glutamate receptors against intraventricular kainate in the rat.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

The metabotropic glutamate receptors: structure and functions

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Interaction of 1-methyl-4-phenylpyridinium ion (MPP+) and its analogs with the rotenone/piericidin binding site of NADH dehydrogenase.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Characterization of the in vivo release of dopamine as recorded by different types of intracerebral microdialysis probes

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

In vivo protection of striatum from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Blockade of 1-methyl-4-phenylpyridinium ion (MPP+) nigral toxicity in the rat by prior decortication or MK-801 treatment: a stereological estimate of neuronal loss

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

1-Methyl-4-phenylpyridinium produces excitotoxic lesions in rat striatum as a result of impairment of oxidative metabolism.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Scope and limitations of in vivo brain dialysis: a comparison of its application to various neurotransmitter systems

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1046%2FJ.1471-4159.2001.00056.X

21 January 2018

Identifiers

10.1046/J.1471-4159.2001.00056.X

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q32034638&oldid=1588003011"